BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10642279)

  • 1. Pranidipine enhances the action of nitric oxide released from endothelial cells.
    Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
    Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
    Mori T; Takeuchi T; Ohura M; Miyakoda G; Fujiki H; Orito K; Yoshida K; Hirano T; Yamamura Y; Sumida T; Nakaya Y; Satake H; Hata F
    Mol Cell Biochem; 1998 Jan; 178(1-2):335-43. PubMed ID: 9546618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
    Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
    Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways.
    Fukuo K; Yang J; Yasuda O; Mogi M; Suhara T; Sato N; Suzuki T; Morimoto S; Ogihara T
    Circulation; 2002 Jul; 106(3):356-61. PubMed ID: 12119253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
    Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
    Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cells.
    Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Ikeda M; Minota S; Shimada K
    J Hypertens; 2000 Nov; 18(11):1597-604. PubMed ID: 11081772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasorelaxing action of labedipinedilol-A involves endothelial cell-derived NO and eNOS expression caused by calcium influx.
    Liou SF; Wu JR; Lai WT; Sheu SH; Chen IJ; Yeh JL
    J Cardiovasc Pharmacol; 2005 Mar; 45(3):232-40. PubMed ID: 15725948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells.
    Pueyo ME; Arnal JF; Rami J; Michel JB
    Am J Physiol; 1998 Jan; 274(1):C214-20. PubMed ID: 9458730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery.
    Koshita M; Takano H; Nakahira Y; Suzuki H
    Eur J Pharmacol; 1999 Dec; 385(2-3):191-7. PubMed ID: 10607875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide (EDRF) enhances the vasorelaxing effect of dihydropyridine calcium antagonists in isolated human middle cerebral arteries.
    Akopov SE
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):101-4. PubMed ID: 8740241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
    Hirano T; Ohura M; Orito K; Fujiki H; Miyakoda G; Mori T
    Eur J Pharmacol; 1997 Apr; 324(2-3):201-4. PubMed ID: 9145772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell-dependent pathways.
    Fukuo K; Yang J; Suzuki T; Kaimoto T; Takemura Y; Yasuda O; Suhara T; Sato N; Ogihara T
    Hypertens Res; 2003 Jun; 26(6):503-8. PubMed ID: 12862208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
    Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
    Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms.
    Berkels R; Egink G; Marsen TA; Bartels H; Roesen R; Klaus W
    Hypertension; 2001 Feb; 37(2):240-5. PubMed ID: 11230278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High salt intake impairs vascular nitric oxide/cyclic guanosine monophosphate system in spontaneously hypertensive rats.
    Kagota S; Tamashiro A; Yamaguchi Y; Nakamura K; Kunitomo M
    J Pharmacol Exp Ther; 2002 Jul; 302(1):344-51. PubMed ID: 12065736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
    Hirano T; Mori T; Kido M; Toide K; Ohura M; Fujiki H; Orito K; Yoshida K; Ikezono K; Sumida T; Nakayama N; Yabuuchi Y
    Fundam Clin Pharmacol; 1999; 13(6):650-5. PubMed ID: 10626752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
    McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by dihydropyridine-type calcium channel antagonists of cytokine-inducible gene expression in vascular smooth muscle cells.
    Cattaruzza M; Wachter R; Wagner AH; Hecker M
    Br J Pharmacol; 2000 Mar; 129(6):1155-62. PubMed ID: 10725264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.